Literature DB >> 26961489

Adiponectin Promotes Human Jaw Bone Marrow Stem Cell Osteogenesis.

Y Pu1, H Wu1, S Lu2, H Hu2, D Li2, Y Wu3, Z Tang2.   

Abstract

Human jaw bone marrow mesenchymal stem cells (h-JBMMSCs) are multipotent progenitor cells with osteogenic differentiation potential. The relationship between adiponectin (APN) and the metabolism of h-JBMMSCs has not been fully elucidated, and the underlying mechanism remains unclear. The aim of the study was to investigate the effect and mechanism of APN on h-JBMMSC metabolism. h-JBMMSCs were obtained from the primary culture of human jaw bones and treated with or without APN (1 µg/mL). Osteogenesis-related gene expression was evaluated by real-time polymerase chain reaction (PCR), alkaline phosphatase (ALP) activity assay, and enzyme-linked immunosorbent assay (ELISA). To further investigate the signaling pathway, mechanistic studies were performed using Western blotting, immunofluorescence, lentiviral transduction, and SB202190 (a specific p38 inhibitor). Alizarin Red staining showed that APN promoted h-JBMMSC osteogenesis. Real-time PCR, ALP assay, and ELISA showed that ALP, osteocalcin (OCN), osteopontin, and integrin-binding sialoprotein were up-regulated in APN-treated cells compared to untreated controls. Immunofluorescence revealed that adaptor protein containing a pleckstrin homology domain, phosphotyrosine domain, and leucine zipper motif (APPL1) translocated from the nucleus to the cytoplasm with APN treatment. Additionally, the phosphorylation of p38 mitogen-activated protein kinase (MAPK) increased over time with APN treatment. Moreover, knockdown of APPL1 or p38 MAPK inhibition blocked the expression of APN-induced calcification-related genes including ALP, Runt-related transcription factor 2 (RUNX2), and OCN. Furthermore, Alizarin Red staining of calcium nodes was not increased by the knockdown of APPL1 or p38 inhibition. Our data suggest that this regulation is mediated through the APPL1-p38 MAPK signaling pathway. These findings collectively provide evidence that APN induces the osteogenesis of h-JBMMSCs through APPL1-mediated p38 MAPK activation. © International & American Associations for Dental Research 2016.

Entities:  

Keywords:  APPL1; IBSP; RUNX2; osteocalcin; osteopontin; p38 mitogen-activated protein kinases

Mesh:

Substances:

Year:  2016        PMID: 26961489     DOI: 10.1177/0022034516636853

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  8 in total

1.  Adiponectin improves the therapeutic efficacy of mesenchymal stem cells by enhancing their engraftment and survival in the peri-infarct myocardium through the AMPK pathway.

Authors:  Xia-Qiu Tian; Xiao-Song Qian; Hong Wang; Yue-Jin Yang
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  ADIPONECTIN AS A POTENTIAL BIOMARKER OF LOW BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH METABOLIC SYNDROME.

Authors:  S S Stojanovic; N A Arsenijevic; A Djukic; S Djukic; S Zivancevic Simonovic; M Jovanovic; N Pejnovic; V Nikolic; S Zivanovic; M Stefanovic; D Petrovic
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Apr-Jun       Impact factor: 0.877

3.  Targeting P38 Pathway Regulates Bony Formation via MSC Recruitment during Mandibular Distraction Osteogenesis in Rats.

Authors:  Zi-Hui Yang; Bao-Lei Wu; Chen Ye; Sen Jia; Xin-Jie Yang; Rui Hou; De-Lin Lei; Lei Wang
Journal:  Int J Med Sci       Date:  2016-10-01       Impact factor: 3.738

4.  Adiponectin promotes human jaw bone marrow mesenchymal stem cell chemotaxis via CXCL1 and CXCL8.

Authors:  Yinfei Pu; Mengke Wang; Yingying Hong; Yuwei Wu; Zhihui Tang
Journal:  J Cell Mol Med       Date:  2017-02-08       Impact factor: 5.310

5.  Adiponectin regulates BMSC osteogenic differentiation and osteogenesis through the Wnt/β-catenin pathway.

Authors:  Yiyao Wang; Xiaohui Zhang; Jun Shao; Hanghang Liu; Xian Liu; En Luo
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

6.  HOPX regulates bone marrow-derived mesenchymal stromal cell fate determination via suppression of adipogenic gene pathways.

Authors:  Esther Camp; Stan Gronthos; Chee Ho Hng; Peter Anderson; James Breen; Andrew Zannettino
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

7.  Adiponectin regulates bone mass in AIS osteopenia via RANKL/OPG and IL6 pathway.

Authors:  Hong-Qi Zhang; Long-Jie Wang; Shao-Hua Liu; Jiong Li; Li-Ge Xiao; Guan-Teng Yang
Journal:  J Transl Med       Date:  2019-02-28       Impact factor: 5.531

8.  Adiponectin inhibits lipoplysaccharide-induced inflammation and promotes osteogenesis in hPDLCs.

Authors:  Huan-Huan Wu; Yuan Guo; Yin-Fei Pu; Zhi-Hui Tang
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.